Providing patients with a new way to benefit from naltrexone
Libero’s purpose is to bring a new wave of transdermal treatments for numerous chronic conditions that have been shown to benefit from opioid receptor antagonism
Enabling stable, sustained plasma levels, drug delivery via a transdermal patch is an ideal treatment modality for many chronic conditions
The scale of unmet need and potential of Libero’s lead medicine led to the National Institute of Drug Abuse (NIDA) in the US awarding Libero a 5 year development grant to bring it to market
Benefits of transdermal vs daily oral delivery
In the case of oral naltrexone, spikes in plasma concentration of the primary metabolite β-Naltrexol are also seen, increasing the risk of adverse effects. This is not expected with transdermal use.
Transdermal delivery
Patient-friendly, sustained drug delivery
Unmet need
Targeting conditions with a large and growing unmet need
Expedited regulatory pathway
Leveraging established data on the compounds to reduce time needed to be clinic-ready
Patent-protection
Patented formulations specific to different indications
Enquire now
Give us a call or fill in the form below and we will contact you. We endeavor to answer all inquiries within 24 hours on business days.